We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$8.87B
AUM Growth
+$1.06B
Cap. Flow
+$639M
Cap. Flow %
7.2%
Top 10 Hldgs %
4.17%
Holding
3,246
New
442
Increased
1,245
Reduced
1,198
Closed
351

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$37.2M
2
LIN icon
Linde
LIN
+$31.4M
3
TTWO icon
Take-Two Interactive
TTWO
+$30M
4
FISV
Fiserv Inc
FISV
+$27.4M
5
WMT icon
Walmart Inc
WMT
+$25.5M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$46.1M
2
PYPL icon
PayPal
PYPL
+$31.4M
3
AAPL icon
Apple
AAPL
+$31.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$28M
5
MRK icon
Merck
MRK
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 18.34%
2 Consumer Discretionary 15.85%
3 Healthcare 13.89%
4 Industrials 12.4%
5 Financials 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WATT icon
2676
Energous
WATT
$102M
$133K ﹤0.01%
77
-42
-35% -$76.2K
MRKR icon
2677
Marker Therapeutics
MRKR
$18.7M
$132K ﹤0.01%
4,734
-2,464
-34% -$64.9K
HTBK
2678
DELISTED
Heritage Commerce
HTBK
$131K ﹤0.01%
+11,785
New +$140K
VKTX icon
2679
Viking Therapeutics
VKTX
$4B
$131K ﹤0.01%
21,810
-7,359
-25% -$43.7K
CLSD
2680
DELISTED
Clearside Biomedical
CLSD
$130K ﹤0.01%
1,777
+404
+29% +$18.8K
LFCR icon
2681
Lifecore Biomedical
LFCR
$190M
$130K ﹤0.01%
+11,580
New +$133K
ACET icon
2682
Adicet Bio
ACET
$74.7M
$129K ﹤0.01%
+782
New +$159K
ASMB icon
2683
Assembly Biosciences
ASMB
$529M
$129K ﹤0.01%
2,773
-2,304
-45% -$114K
GSKY
2684
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$128K ﹤0.01%
23,102
-84,950
-79% -$509K
CTIC
2685
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$128K ﹤0.01%
51,287
+26,266
+105% +$63K
KBAL
2686
DELISTED
Kimball International
KBAL
$126K ﹤0.01%
+9,544
New +$130K
DHC
2687
Diversified Healthcare Trust
DHC
$2.14B
$125K ﹤0.01%
30,005
-2,410
-7% -$9.95K
FRO icon
2688
Frontline
FRO
$8.85B
$124K ﹤0.01%
13,781
-1,320
-9% -$10.6K
NKLA
2689
DELISTED
Nikola Corporation Common Stock
NKLA
$123K ﹤0.01%
+227
New +$94.6K
LSXMK
2690
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$123K ﹤0.01%
3,421
-6,744
-66% -$232K
MILE
2691
DELISTED
Metromile, Inc. Common Stock
MILE
$123K ﹤0.01%
13,425
-143,059
-91% -$1.28M
CTRM icon
2692
Castor Maritime
CTRM
$19.7M
$122K ﹤0.01%
4,675
+4,420
+1,733% +$180K
FINV
2693
FinVolution Group
FINV
$1.15B
$122K ﹤0.01%
12,815
-290,361
-96% -$2.2M
CABA icon
2694
Cabaletta Bio
CABA
$455M
$120K ﹤0.01%
+13,928
New +$137K
GTHX
2695
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$119K ﹤0.01%
5,409
-6,029
-53% -$134K
ZEPP
2696
Zepp Health
ZEPP
$69.7M
$118K ﹤0.01%
2,518
-7,004
-74% -$292K
TTOO
2697
DELISTED
T2 Biosystems, Inc
TTOO
$118K ﹤0.01%
20
+8
+67% +$51.7K
EVFM
2698
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$118K ﹤0.01%
6,958
+1,573
+29% +$29.8K
AXTI icon
2699
AXT Inc
AXTI
$5.8B
$116K ﹤0.01%
10,546
-435
-4% -$4.62K
UTHR icon
2700
United Therapeutics
UTHR
$23.1B
$116K ﹤0.01%
645
-6,248
-91% -$1.19M
106 107
108
109 110

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q2 2021 Portfolio in Review

As of Q2 2021, Cubist Systematic Strategies held 3,246 positions worth $8.87B, up 14% from $7.81B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Cubist Systematic Strategies deployed $639M of net new capital in Q2 2021, opening 442 new positions and adding to 1,245 existing holdings. Its largest new stake was American Tower: 39,022 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Aptiv, an estimated $46.1M trimmed.

  • Cubist Systematic Strategies's largest Q2 2021 buy was American Tower: 39,022 shares worth $10.5M.
  • Cubist Systematic Strategies added most to Okta in Q2 2021, an estimated $37.2M increase.
  • Cubist Systematic Strategies's biggest Q2 2021 reduction was Aptiv, cutting an estimated $46.1M.
  • Cubist Systematic Strategies fully exited Toro Company in Q2 2021, selling an estimated $7.31M.
  • Cubist Systematic Strategies's ten largest holdings make up 4.2% of its $8.87B portfolio in Q2 2021.
  • Cubist Systematic Strategies opened 442 new positions and closed 351 in Q2 2021.
  • Cubist Systematic Strategies's portfolio value rose 14% quarter-over-quarter to $8.87B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.